Insulin lispro

Chemical formula: C₂₅₇H₃₈₉N₆₅O₇₇S₆  Molecular mass: 5,811.691 g/mol 

Therapeutic indications

Insulin lispro is indicated for:

Diabetes mellitus

Population group: only adults (18 years old or older)

For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Insulin lispro is also indicated for the initial stabilisation of diabetes mellitus.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Insulin lispro is contraindicated in the following cases:

Hypoglycaemia

Hypoglycaemia

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: ADMELOG Solution for injection
Summary of Product Characteristics (SPC) 2018: HUMALOG 100 units/ml Solution for injection in vial / Cartridge / KwikPen - Junior KwikPen
Summary of Product Characteristics (SPC) 2018: HUMALOG Mix50 100 units/ml Suspension for injection in cartridge / KwikPen pre-filled pen
Summary of Product Characteristics (SPC) 2018: HUMALOG Mix25 100 units/ml Suspension for injection in vial / cartridge / KwikPen pre-filled pen
Summary of Product Characteristics (SPC) 2018: HUMALOG 200 units/ml Solution for injection KwikPen pre-filled pen
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈